An edition of Nonmelanocytic Tumors of the Skin (Atlas of Tumor Pathology Series IV)
(2006)
Nonmelanocytic Tumors of the Skin (Atlas of Tumor Pathology Series IV)
1 edition
by James W. Patterson
- 0 Ratings
- 0 Want to read
- 0 Currently reading
- 0 Have read
Share
×Close
This edition doesn't have a description yet. Can you add one?
Check nearby libraries
Buy this book
Showing 1 featured edition. View all 1 editions?
| Edition | Availability |
|---|---|
1
Nonmelanocytic Tumors of the Skin (Atlas of Tumor Pathology Series IV)
January 30, 2006, American Registry of Pathology
Hardcover
in English
- 1 edition
1881041980 9781881041986
|
aaaa
Libraries near you:
WorldCat
|
Book Details
Table of Contents
1.
Epidermal Tumors
1.1.
Epithelial Cysts
1.1.1.
Epidermal Cyst and Milium
1.1.2.
Human Papillomavirus-Associated Cyst (Verrucous Cyst)
1.1.3.
Proliferating Epidermal Cyst
1.1.4.
Pigmented Follicular Cyst
1.1.5.
Cutaneous Keratocyst
1.1.6.
Epithelial Cysts in Gardner's Syndrome
1.1.7.
Trichilemmal Cyst (Pilar Cyst, Isthmus-Catagen Cyst)
1.1.8.
Proliferating Trichilemmal Cyst (Proliferating Trichilemmal Tumor, Pilar Tumor, Proliferating Pilar Tumor)
1.1.9.
Steatocystoma
1.1.10.
Dermoid Cyst
1.1.11.
Eruptive Vellus Hair Cyst
1.1.12.
Cutaneous Cysts and Related Structures That May Be Ciliated
1.1.13.
Other Cutaneous Cysts
1.2.
Benign Epidermal Tumors
1.2.1.
Epidermal Nevus
1.2.2.
Acantholytic Acanthoma
1.2.3.
Epidermolytic Acanthoma
1.2.4.
Warty Dyskeratoma
1.2.5.
Seborrheic Keratosis and Its Variants
1.2.6.
Large Cell Acanthoma
1.2.7.
Clear Cell Acanthoma
1.2.8.
Clear Cell Papulosis
1.2.9.
Pseudoepitheliomatous Hyperplasia
1.3.
Premalignant and Malignant Epidermal Tumors
1.3.1.
Actinic Keratosis
1.3.2.
Porokeratosis
1.3.3.
Bowen's Disease (Squamous Cell Carcinoma In Situ)
1.3.4.
Erythroplasia of Queyrat
1.3.5.
Bowenoid Papulosis
1.3.6.
Squamous Cell Carcinoma
1.3.7.
Verrucous Carcinoma
1.3.8.
Keratoacanthoma
1.3.9.
Adenosquamous Carcinoma
1.3.10.
Sarcomatoid Carcinoma (Carcinosarcoma, Metaplastic Carcinoma)
1.3.11.
Lymphoepithelioma-Like Carcinoma
1.3.12.
Basal Cell Carcinoma
2.
Neoplastic and Pseudoneoplastic Lesions of the Hair Follicles
2.1.
Benign Follicular Neoplasms with Nongerminative Cellular Differentiation
2.1.1.
Tumor of the Follicular Infundibulum
2.1.2.
Pilar Sheath Acanthoma
2.1.3.
Winer's Pore
2.1.4.
Trichoadenoma
2.1.5.
Trichilemmoma
2.1.6.
Benign Proliferating Pilar Tumor
2.2.
Benign Follicular Neoplasms with Germinative-Type Differentiation
2.2.1.
Trichofolliculoma
2.2.2.
Trichoepithelioma
2.2.3.
Desmoplastic Trichoepithelioma
2.2.4.
Pilomatricoma
2.2.5.
Trichogerminoma
2.3.
Mixed Epithelial and Mesenchymal Follicular Proliferations
2.3.1.
Basaloid Follicular Hamartoma
2.3.2.
Trichoblastoma
2.4.
Neoplasms Showing Differentiation Towards Follicle-Related Mesenchyme
2.4.1.
Trichodiscoma
2.4.2.
Perifollicular Fibroma
2.4.3.
Fibrofolliculoma
2.4.4.
Follicular Myxoma
2.4.5.
Pilar Leiomyoma
2.5.
Malignant Pilar Neoplasms
2.5.1.
Trichilemmal Carcinoma
2.5.2.
Malignant Proliferating Pilar Tumor
2.5.3.
Pilomatrix Carcinoma
2.5.4.
Adnexal Carcinomas with Mixed Differentiation
2.5.5.
Pilar Leiomyosarcoma
2.6.
Pseudoneoplastic Proliferations of Hair Follicles and Follicle-Related Mesenchyme
2.6.1.
Hair Follicle Nevus
2.6.2.
Linear Basal Cell Nevus
2.6.3.
Steatocystoma Multiplex and Simplex
2.6.4.
Eruptive Vellus Hair Cyst
2.6.5.
Neurofollicular and Pilar Neurocristic Hamartomas
3.
Tumors and Tumor-Like Conditions with Predominantly Sebaceous Differentiation
3.1.
Pseudoneoplastic Sebaceous Proliferations
3.1.1.
Sebaceous Hyperplasia
3.1.2.
Nevus Sebaceus
3.2.
Benign Sebaceous Neoplasms
3.2.1.
Sebaceous Adenoma
3.2.2.
Superficial Epithelioma with Sebaceous Differentiation
3.2.3.
Sebaceoma
3.3.
Borderline Sebaceous Neoplasms
3.3.1.
Basal Cell Carcinoma with Sebaceous Differentiation
3.4.
Malignant Sebaceous Neoplasms
3.4.1.
Sebaceous Carcinoma
4.
Neoplasms and Pseudoneoplastic Proliferations of the Sweat Glands, and Primary Neuroendocrine (Merkel Cell) Carcinoma
4.1.
Benign Eccrine Sweat Gland Neoplasms
4.1.1.
Eccrine Cylindroma
4.1.2.
Eccrine Spiradenoma
4.1.3.
Syringoma
4.1.4.
Eccrine Poroma
4.1.5.
Eccrine Syringofibroadenoma
4.1.6.
Papillary Eccrine Adenoma (Tubulopapillary Eccrine Hidradenoma)
4.1.7.
Eccrine Acrospiroma (Solid and Cystic Hidradenoma, Nodular Eccrine Hidradenoma)
4.2.
Benign Apocrine Sweat Gland Neoplasms
4.2.1.
Syringocystadenoma Papilliferum
4.2.2.
Hidradenoma Papilliferum
4.2.3.
Tubular Apocrine Adenoma
4.3.
Sweat Gland Tumors With Mixed Differentiation
4.3.1.
Benign Mixed Tumors of the Skin (Chondroid Syringoma)
4.3.2.
Other Mixed Lineage Adnexal Tumors
4.4.
Malignant Sweat Gland Tumors
4.4.1.
Eccrine Carcinomas
4.4.2.
Eccrine Carcinomas That Are Histologically Definable as Primary Tumors
4.4.3.
Eccrine Carcinomas That Histologically Simulate Metastatic Tumors
4.4.4.
Apocrine Carcinomas
4.4.5.
Apocrine Carcinomas That Are Histologically Definable as Primary Tumors
4.4.6.
Apocrine Carcinomas That May Histologically Simulate Metastases
4.5.
Adnexal Carcinomas of Uncertain or Mixed Lineage, with Sweat Glandular Elements
4.5.1.
Lymphoepithelioma-Like Carcinoma
4.5.2.
Adnexal Carcinoma with Mixed Differentiation
4.6.
Primary Neuroendocrine (Merkel Cell) Carcinoma
4.7.
Pseudoneoplastic Lesions of Sweat Glands
4.7.1.
Eccrine and Apocrine Nevi
4.7.2.
Syringometaplasia
4.7.3.
Eccrine and Apocrine Hidrocystomas
5.
Metastatic Neoplasms
5.1.
Visceral Carcinomas That Involve the Skin
5.1.1.
Clinical Features
5.1.2.
Pathologic Findings
5.1.3.
Specific Visceral Sources of Cutaneous Metastasis
5.1.4.
Immunohistochemistry in the Determination of Primary Site
5.2.
Primary Nonadnexal Epithelial Skin Tumors That May Resemble Metastatic Lesions
5.3.
Other Metastatic Neoplasms
6.
Fibrous Tissue Tumors
6.1.
Benign Fibrous Tissue Tumors
6.1.1.
Fibroepithelial Polyps
6.1.2.
Connective Tissue Nevus
6.1.3.
Fibrous Hamartoma of Infancy
6.1.4.
Dermatofibroma
6.1.5.
Dermatomyofibroma
6.1.6.
Angiofibroma and Related Lesions
6.1.7.
Plexiform Fibrohistiocytic Tumor
6.1.8.
Superficial Acral Fibromyxoma
6.1.9.
Pleomorphic Fibroma
6.1.10.
Sclerotic Fibroma
6.1.11.
Collagenous Fibroma (Desmoplastic Fibroblastoma)
6.1.12.
Postoperative Spindle Cell Nodule
6.1.13.
Inflammatory Pseudotumor
6.1.14.
Keloid
6.1.15.
Elastofibroma Dorsi
6.1.16.
Giant Cell Tumor of Tendon Sheath
6.1.17.
Peripheral Giant Cell Granuloma (Giant Cell Epulis)
6.1.18.
Fibroma of Tendon Sheath
6.1.19.
Fibromatosis
6.1.20.
Recurrent Infantile Digital Fibroma
6.1.21.
Myofibroma
6.1.22.
Juvenile Hyaline Fibromatosis
6.1.23.
Nodular Fasciitis
6.2.
Fibrous Tissue Tumors of Intermediate Malignancy
6.2.1.
Solitary Fibrous Tumor
6.2.2.
Dermatofibrosarcoma Protuberans
6.2.3.
Bednar's Tumor (Pigmented Dermatofibrosarcoma Protuberans)
6.2.4.
Giant Cell Fibroblastoma
6.2.5.
Aggressive Angiomyxoma, Superficial Angiomyxoma, and Angiomyofibroblastoma
6.2.6.
Low-Grade Fibromyxoid Sarcoma
6.2.7.
Atypical Fibroxanthoma
6.3.
Malignant Fibrous Tissue Tumors
6.3.1.
Malignant Fibrous Histiocytoma
6.3.2.
Epithelioid Sarcoma
6.3.3.
Synovial Sarcoma
6.3.4.
Fibrosarcoma
7.
Vascular Tumors and Pseudotumors
7.1.
Vascular Nevus
7.2.
Benign Vascular Neoplasms
7.2.1.
Lymphangioma
7.2.2.
Cavernous and Capillary Hemangiomas
7.2.3.
Lobular Capillary Hemangioma (Pyogenic Granuloma) and Related Lesions
7.2.4.
Kimura's Disease
7.2.5.
Epithelioid (Histiocytoid) Hemangioma
7.2.6.
Acral Arteriovenous Tumor/(Arterio-)Venous Hemangioma
7.2.7.
Hobnail/Targetoid/"Atypical" Hemangioma
7.2.8.
Other Cutaneous Hemangioma Variants
7.2.9.
Angiokeratoma
7.3.
Borderline Vascular Tumors
7.3.1.
Papillary Endovascular (Intralymphatic?) Angioendothelioma
7.3.2.
Epithelioid Hemangioendothelioma
7.3.3.
Spindle Cell Hemangioendothelioma (Hemangioma)
7.3.4.
Kaposiform Hemangioendothelioma
7.3.5.
Retiform Hemangioendothelioma
7.3.6.
Other Hemangioendotheliomas
7.4.
Malignant Vascular Neoplasms
7.4.1.
Kaposi's Sarcoma
7.4.2.
Angiosarcoma
7.5.
Tumefactive Non-Neoplastic Vascular Proliferations
7.5.1.
Lesions That Simulate Kaposi's Sarcoma
7.5.2.
Potential Simulators of Angiosarcoma
7.5.3.
Other Reactive Vascular Proliferations
8.
Tumors and Tumor-Like Conditions Showing Neural, Nerve Sheath, and Adipocytic Differentiation
8.1.
Neural Lesions
8.1.1.
Neuroma and Ganglioneuroma
8.1.2.
Neurofibroma
8.1.3.
Neurilemmoma
8.1.4.
Neurothekeoma
8.1.5.
Benign Granular Cell Tumor
8.1.6.
Peripheral Neuroepithelioma/Primitive Neuroectodermal Tumor
8.1.7.
Nonepithelioid Malignant Peripheral Nerve Sheath Tumor
8.1.8.
Epithelioid Malignant Peripheral Nerve Sheath Tumor
8.1.9.
Malignant Granular Cell Tumor
8.2.
Pseudotumors of the Skin Related to the Nervous System
8.2.1.
Rudimentary Meningocele (Primary Cutaneous Meningioma, Meningotheliomatous Hamartoma)
8.2.2.
Cutaneous Glial Heterotopia (Nasal Glioma)
8.3.
Tumors with Adipocytic Differentiation
8.3.1.
Lipoma Variants
8.3.2.
Lipoblastoma
8.3.3.
Hibernoma
8.4.
Adipocytic Pseudotumors
8.4.1.
Nevus Lipomatosus
8.4.2.
Tumefactive Localized Lipedema
9.
Tumors of Muscle, Cartilage, and Bone
9.1.
Smooth Muscle Tumors
9.1.1.
Smooth Muscle Hamartoma
9.1.2.
Leiomyoma
9.1.3.
Cutaneous Angiomyolipoma (Angiolipoleiomyoma)
9.1.4.
Leiomyosarcoma
9.2.
Striated Muscle Tumors and Rhabdoid Tumor
9.2.1.
Rhabdomyomatous Mesenchymal Hamartoma
9.2.2.
Rhabdomyosarcoma
9.2.3.
(Extrarenal) Malignant Rhabdoid Tumor
9.3.
Cartilaginous Tumors and Parachordoma
9.3.1.
Extraskeletal Chondroma
9.3.2.
Subungual Osteochondroma and Exostosis
9.3.3.
Parachordoma
9.3.4.
Chondrosarcoma
9.4.
Calcifying and Ossifying Tumors
9.4.1.
Ossifying Fibromyxoid Tumor
9.4.2.
Fibro-osseous Pseudotumor of the Digits
9.4.3.
Calcifying Aponeurotic Fibroma
9.4.4.
Osteosarcoma
10.
Histiocytic Proliferations
10.1.
Non-Langerhans Cell Histiocytic Infiltrates
10.1.1.
(Juvenile) Xanthogranuloma
10.1.2.
Benign Cephalic Histiocytosis
10.1.3.
Progressive Nodular Histiocytosis
10.1.4.
Generalized Eruptive Histiocytoma
10.1.5.
Xanthoma Disseminatum
10.1.6.
Reticulohistiocytosis
10.1.7.
Familial Histiocytic Dermatoarthritis
10.1.8.
Rosai-Dorfman Disease (Sinus Histiocytosis with Massive Lymphadenopathy)
10.2.
Malignant Histiocytosis
10.3.
Langerhans Cell Histiocytosis and Indeterminate Cell Histiocytosis
10.3.1.
Langerhans Cell Histiocytosis
10.3.2.
Congenital Self-Healing Reticulohistiocytosis
10.3.3.
Indeterminate Cell Histiocytosis
11.
Plasmacellular Infiltrative Disorders
11.1.
Multiple Myeloma
11.2.
Extraosseous Plasmacytoma
11.3.
Macroglobulinemia of Waldenstrom
11.4.
Castleman's Disease
12.
Cutaneous Mastocytosis
12.1.
Systemic Mastocytosis
12.2.
Cutaneous Mastocytosis (Urticaria Pigmentosa)
13.
Lymphoid Infiltrates, Lymphoma, and Hematopoietic Proliferations
13.1.
Lymphoid Infiltrates and Lymphomas
13.2.
Lymphocytoma Cutis (Reactive Lymphoid Infiltrate, Cutaneous Lymphoid Hyperplasia, Pseudolymphoma, Lymphadenosis Benigna Cutis)
13.3.
B-Cell Neoplasms
13.3.1.
Cutaneous Marginal Zone B-Cell Lymphoma (Mucosa-Associated Lymphoid Tissue [MALT] Lymphoma)
13.3.2.
Follicular Lymphoma
13.3.3.
Diffuse Large B-Cell Lymphoma
13.3.4.
Intravascular Large B-Cell Lymphoma
13.3.5.
Lymphomatoid Granulomatosis
13.3.6.
Other B-Cell Lymphomas Involving the Skin
13.4.
T-Cell and NK-Cell Neoplasms
13.4.1.
Precursor T-Cell Lymphoblastic Lymphoma
13.4.2.
Adult T-Cell Leukemia/Lymphoma
13.4.3.
Extranodal NK/T-Cell Lymphoma, Nasal Type
13.4.4.
Subcutaneous Panniculitis-Like T-Cell Lymphoma
13.4.5.
Mycosis Fungoides
13.4.6.
Pagetoid Reticulosis
13.4.7.
Granulomatous Slack Skin
13.4.8.
Sézary's Syndrome
13.4.9.
Primary and Secondary Cutaneous Anaplastic Large Cell Lymphoma
13.4.10.
Peripheral T-Cell Lymphoma, Not Further Specified (Including Lennert's Lymphoma)
13.4.11.
Angioimmunoblastic T-Cell Lymphoma
13.4.12.
Lymphomatoid Papulosis
13.4.13.
Other T-Cell and NK-Cell Lymphomas Involving the Skin
13.5.
Cutaneous Involvement in Hodgkin's Disease
13.6.
Leukemia Cutis
13.7.
Extramedullary Hematopoiesis
The Physical Object
ID Numbers
Community Reviews (0)
Feedback?
| May 23, 2012 | Edited by Fe Rien | Edited without comment. |
| December 10, 2009 | Created by WorkBot | add works page |